VISTAGEN THERAPEUTICS, INC. Conversion of Stock, Shares Issued
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Conversion of Stock, Shares Issued of 716 shares for the 1-month period ending 2016-02-12, per its 10-Q filed 2016-02-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2016-02-16
- 2016-02-12: Conversion of Stock, Shares Issued 1 month 716.00 shares.
- 2015-11-13: Conversion of Stock, Shares Issued 1 month 542.00 shares.
| Period end | Conversion of Stock, Shares Issued 1 month |
|---|---|
| 2016-02-12 | 716.00 shares 10-Q · filed 2016-02-16 |
| 2015-11-13 | 542.00 shares 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |